首页|探索药物靶点:寻找"头雁分子"

探索药物靶点:寻找"头雁分子"

扫码查看
新药发现的关键之一是药物靶点,本文探讨了新药研究中对药物靶点的研究和一些思考。虽然一个哺乳动物细胞可以有几万个蛋白质分子,但真正起关键性作用的只有极少数,它们的功能配置如同大雁群在迁徙飞行中的"头雁效应"。从治疗疾病的角度看,我们称这些极少数关键分子为"头雁分子";在细胞环境支持的条件下它们可以接受药物的调节并发出指令信息(如蛋白修饰等),由此带领大多数其他相关蛋白分子协同完成重编程的任务,产生有效且安全性较好的治疗效果。这些"头雁分子"可能是最好的药物靶点。本文以AMPK、GLP-1受体和LDLR为例,展示了这些"头雁分子"在能量代谢和脂质代谢中的核心地位。未来新药研究中的挑战在于如何在复杂的蛋白质网络中识别这些头雁分子,并理解它们如何与环境条件相互作用以产生疗效,以期实现标本兼治的治疗目标,即通过增加机体的负熵作用来改善健康。
Drug target is a key in drug discovery. Although cells have over 30000 proteins,for particular cellular function only few of the proteins are critical. The biological role of the critical proteins could be described as "head goose effect",and these molecules could be called "head goose molecules (HGMs)". We assume that under the support from intra-or extra-cellular circumstances the HGMs could be regulated by drugs,then release instructive signals (for instance,protein modification) to other proteins. Through proper cooperation of the HGMs with other protein molecules the disease cell could be reprogrammed,yielding safe and therapeutic effects. Therefore,HGMs might be the best drug targets. Here,we show good HGM examples in energy metabolism,and drugs that target the metabolic HGMs are quite successful in clinic. We hope the thought interest for those working on drug target discovery.

drug targetdrug designhead goose molecules

李瑞、任刚、韩燕星、王璐璐、蒋建东

展开 >

100050 北京,中国医学科学院北京协和医学院医药生物技术研究所病毒研究室

100050 北京,中国医学科学院北京协和医学院药物研究所重点室

药物靶点 药物设计 头雁分子

2024

中国医药生物技术
中国医药生物技术协会

中国医药生物技术

CSTPCD
影响因子:0.368
ISSN:1673-713X
年,卷(期):2024.19(6)